AFT Pharmaceuticals Limited (ASX:AFT) Announces Half-Year Results
AFT Pharmaceuticals Limited reports increased revenue but a significant decline in net profit for the half-year ending September 30, 2024.
AFT Pharmaceuticals Limited reports increased revenue but a significant decline in net profit for the half-year ending September 30, 2024.
AFT Pharmaceuticals (ASX:AFP) announces record sales in H1 FY25 and a positive outlook for future growth.
Pacific Smiles Group reports strong FY24 results and guides for FY25 growth while addressing a takeover bid from Genesis Bidco.